Pedro Chorao
Valencia, VC, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 56 publications
Outcomes of Allogeneic Hematopoietic Cell Transplantation with Post-Transplant Cyclophosphamide Prophylaxis in Myelodysplastic Syndromes: A Multicenter Study Conducted on Behalf of GETH-TC.
Journal: Transplantation and cellular therapy
Published: February 13, 2026
Outcomes of Allogeneic Hematopoietic Cell Transplantation with Post-Transplant Cyclophosphamide Prophylaxis in Myelodysplastic Syndromes: A Multicenter Study Conducted on Behalf of GETH-TC.
Journal: Transplantation and cellular therapy
Published: February 13, 2026
Real-World Outcomes of FLAG-Ida Regimen in 1079 Adult Patients With First Relapsed/Refractory AML: A PETHEMA Study.
Journal: American journal of hematology
Published: February 05, 2026
Bone Marrow Transplantation From Matched and Mismatched Unrelated Donors With Post-Transplant Cyclophosphamide for Patients With Severe Aplastic Anemia.
Journal: Transplantation and cellular therapy
Published: November 12, 2025
Evolving Patterns of EBV-Associated PTLD After Allogeneic Stem Cell Transplantation: Frequency, Characteristics and Outcomes in a Multicenter GETH-TC Study.
Journal: European journal of haematology
Published: November 08, 2025
Unveiling CMV Risk Signatures After Allogeneic Stem Cell Transplantation Through Machine Learning Approaches: A Multicenter Analysis From the GETH-TC.
Journal: Journal of medical virology
Published: November 06, 2025
The Rise of Fine-Tuned CAR-Based Therapies Against Acute Myeloid Leukemia.
Journal: Cancers
Published: October 20, 2025
Vaccination as a Key Determinant of Influenza Disease Severity in Allogeneic Hematopoietic Stem Cell Transplant Recipients: An Observational Retrospective Study.
Journal: Open forum infectious diseases
Published: October 06, 2025
Allogeneic hematopoietic stem cell transplantation after azacitidine and venetoclax salvage in relapsed/refractory AML: a multicenter real-world study by the French AURAML group.
Journal: Bone marrow transplantation
Published: October 01, 2025
Chronic graft-versus-host disease in the era of posttransplant cyclophosphamide.
Journal: Haematologica
Published: September 28, 2025
Incidence and outcome of hemorrhagic cystitis after allogeneic hematopoietic cell transplantation: a survey of the infectious diseases working party of EBMT.
Journal: Bone marrow transplantation
Published: September 19, 2025
Clinicopathologic Features and Outcomes of Actinic Keratosis and Skin Cancer After Hematopoietic Stem Cell Transplantation.
Journal: International journal of dermatology
Published: September 16, 2025
Last Updated: 09/26/2026